+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04313140

Developing a Virtual Biopsy to Determine Glioma Tumor Grade Using Advanced MRI Techniques at Poitiers University Hospital

Led by Poitiers University Hospital · Updated on 2026-05-08

500

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Glioma is a type of tumor affecting the central nervous system. The study aims to develop a virtual biopsy method to identify the grade of a patients glioma using magnetic resonance imaging MRI instead of traditional anatomical biopsy. This approach uses artificial intelligence algorithms to improve tumor grading and assist in treatment decisions. Participants will undergo a single diagnostic test lasting about 2 hours and 30 minutes, which includes a clinical MRI and additional research MRI techniques such as phosphorus spectroscopy and sodium imaging. This detailed MRI examination is designed to collect imaging data that will be analyzed using statistical learning algorithms to validate the virtual biopsy against actual biopsy results. During the study, participants will have their glioma grade assessed through the MRI procedure. Researchers will compare the virtual biopsy results with biopsy findings to evaluate accuracy. The main outcome measure is the validation of the virtual biopsy using artificial intelligence compared to the traditional biopsy. Participation involves one study visit for the MRI exam, with informed consent and follow-up as needed.

CONDITIONS

Brief Title

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Research Team

R

Rémy GUILLEVIN, Pr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here